Despite health department funding, Michigan has no state law explicitly authorizing SSP—but does have local ordinances against syringe access.

The new approval allows patients to transition to a single 200mg subcutaneous injection once every 4 weeks, following completion of the induction phase.

Learn more about the critical tests for ensuring the proper performance of auto-injectors, which are used for a variety of ...

A severely anorexic young woman was prescribed blockbuster weight loss jab Wegovy by one of the UK's biggest online ...

A coalition of news organizations is suing Tennessee’s top prisons official and a warden, alleging that state execution ...

Regeneron is planning to re-apply to the FDA with a new pre-filled syringe manufacturing filler in January 2026.

The MarketWatch News Department was not involved in the creation of this content. Vabysmo now covered across all three approved indications in the province, providing patients with a comprehensively ...

The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...

SAN DIEGO, April 10, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that argenx has received U.S. Food and Drug Administration (FDA) approval of VYVGART ® ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved the ...